OR WAIT null SECS
January 28, 2022
Catalent has expanded its Malvern, Pennsylvania, USA, and Dartford, UK, facilities to provide advanced containment capabilities for the micronization of highly potent drug compounds.
January 27, 2022
Merger with Phlexglobal expands provider’s technological capabilities.
A collaboration and licensing agreement has been entered into by the Queen’s University Belfast and Ipsen.
BIA and Clarivate have released new data that show there was a jump of 60% in investments into biotech and life sciences companies in the UK during 2021.
Stevanato Group has extended its licensing agreement with Haselmeier for its Axis-D pen injector technology.
January 21, 2022
A report by international regulators reviews the effectiveness of current COVID-19 vaccines against the omicron variant.
AstraZeneca's Tagrisso has been accepted for use as a monotherapy for the first-line treatment of adult patients with locally advanced or metastatic NSCLC with activating EGFR mutations in Scotland.
Air France KLM Martinair Cargo and Envirotainer are collaborating on more sustainable air transport of pharmaceuticals
PharmaLex Group has merged with MAP Group, broadening its market access expertise and extending its reach into the Italian marketplace.
Cyxone has appointed a European CDMO to scale-up and produce the active ingredient of its T20K drug candidate.